Zymeworks Inc. financial data

Symbol
ZYME on Nasdaq
Industry
Pharmaceutical Preparations
Location
108 Patriot Drive, Suite A, Middletown, DE
Fiscal year end
December 31
Former names
Zymeworks Delaware Inc. (to 10/13/2022)
Latest financial report
10-K - Q4 2024 - Mar 5, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 501 % -11.3%
Debt-to-equity 30.3 % +3.91%
Return On Equity -31.7 % -20.8%
Return On Assets -24.3 % -19.8%
Operating Margin -180 % +1.06%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 69.6M shares -1.41%
Common Stock, Shares, Outstanding 69M shares -1.64%
Entity Public Float 488M USD +4.18%
Common Stock, Value, Issued 1.02B USD +1.84%
Weighted Average Number of Shares Outstanding, Basic 75.8M shares +10.1%
Weighted Average Number of Shares Outstanding, Diluted 75.9M shares +10.2%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 76.3M USD +0.38%
Research and Development Expense 130M USD -32.4%
General and Administrative Expense 61.5M USD -12.7%
Costs and Expenses 213M USD -0.3%
Operating Income (Loss) -137M USD +0.68%
Nonoperating Income (Expense) 558K USD
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -117M USD +2.21%
Income Tax Expense (Benefit) 6.08M USD
Net Income (Loss) Attributable to Parent -123M USD -3.39%
Earnings Per Share, Basic -1.62 USD/shares +5.81%
Earnings Per Share, Diluted -1.62 USD/shares +5.81%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 66.1M USD -58%
Accounts Receivable, after Allowance for Credit Loss, Current 55.8M USD +187%
Assets, Current 300M USD -27.2%
Deferred Income Tax Assets, Net 4.39M USD +21.3%
Property, Plant and Equipment, Net 17.7M USD -11.1%
Operating Lease, Right-of-Use Asset 16.7M USD -5.82%
Goodwill 12M USD 0%
Assets 463M USD -20.3%
Employee-related Liabilities, Current 6.22M USD +1.12%
Contract with Customer, Liability, Current 25.6M USD +592%
Liabilities, Current 88.3M USD +58.3%
Contract with Customer, Liability, Noncurrent 14.6M USD -55.7%
Deferred Income Tax Liabilities, Net 4.76M USD +44.3%
Operating Lease, Liability, Noncurrent 15.7M USD -29.6%
Other Liabilities, Noncurrent 923K USD -45.7%
Liabilities 124M USD +7.11%
Accumulated Other Comprehensive Income (Loss), Net of Tax -6.95M USD -5.29%
Retained Earnings (Accumulated Deficit) -830M USD -22.6%
Stockholders' Equity Attributable to Parent 339M USD -27.1%
Liabilities and Equity 463M USD -20.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -37.7M USD +54.7%
Net Cash Provided by (Used in) Financing Activities 2.12M USD +22.2%
Net Cash Provided by (Used in) Investing Activities -7.32M USD +94.7%
Common Stock, Shares Authorized 900M shares 0%
Common Stock, Shares, Issued 69M shares -1.64%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -42.7M USD +80.5%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 66.1M USD -58%
Deferred Tax Assets, Valuation Allowance 249M USD +12.3%
Deferred Tax Assets, Gross 258M USD +9.73%
Operating Lease, Liability 18.5M USD -30.6%
Depreciation 1.06M USD -33%
Payments to Acquire Property, Plant, and Equipment 185K USD -52.1%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -123M USD -3.73%
Lessee, Operating Lease, Liability, to be Paid 21.4M USD -31.7%
Property, Plant and Equipment, Gross 35.5M USD -12.4%
Operating Lease, Liability, Current 2.74M USD -35.7%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 2.95M USD -38%
Deferred Tax Assets, Operating Loss Carryforwards 658M USD +10.2%
Preferred Stock, Shares Issued 1 shares 0%
Preferred Stock, Shares Authorized 100M shares 0%
Unrecognized Tax Benefits 3.12M USD +1.24%
Operating Lease, Payments 4.15M USD -15.2%
Preferred Stock, Shares Outstanding 1 shares 0%
Amortization of Intangible Assets 702K USD +3.39%
Deferred Tax Assets, Net of Valuation Allowance 4.39M USD +21.3%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%